Although composite indicators are widely used to inform health system performance comparisons, such measures typically embed contentious assumptions, for instance about the weights assigned to constituent indicators. Moreover, although many comparative measures are constructed as ratios, the choice of denominator is not always straightforward. The conventional approach is to determine a single set of weights and to choose a single denominator, even though this involves considerable methodological difficulties. This study proposes an alternative approach to handle incomplete information about an appropriate set of weights and about a defensible denominator in composite indicators which considers all feasible weights and can incorporate multiple denominators. We illustrate this approach for comparative quality assessments of Scottish Health Boards. The results (displayed as ranking intervals and dominance relations) help identify Boards which cannot be ranked, say, worse than 4th or better than 7th. Such rankings give policy-makers a sense of the uncertainty around ranks, indicating the extent to which action is warranted. By identifying the full range of rankings that the organizations under comparison may attain, the approach proposed here acknowledges imperfect information about the "correct" set of weights and the appropriate denominator and may thus help to increase transparency of and confidence in health system performance comparisons.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.socscimed.2016.06.026DOI Listing

Publication Analysis

Top Keywords

set weights
12
ranking intervals
8
intervals dominance
8
dominance relations
8
scottish health
8
health boards
8
composite indicators
8
health system
8
system performance
8
performance comparisons
8

Similar Publications

The (in)dependence of single-cell data inferences on model constructs.

Forensic Sci Int Genet

January 2025

Center for Computational and Integrative Biology, Rutgers University, Camden, NJ 08102, USA; Department of Computer Science,  Rutgers University, Camden, NJ 08102, USA.

Recent developments in single-cell analysis have revolutionized basic research and have garnered the attention of the forensic domain. Though single-cell analysis is not new to forensics, the ways in which these data can be generated and interpreted are. Modern interpretation strategies report likelihood ratios that rely on a model of the world that is a simplification of it.

View Article and Find Full Text PDF

Background: So-called scores are a frequently used evaluation system in clinical examinations to assess the function or limitations of a joint such as the shoulder. However, research indicates that these general scores often have limited validity for specific patient groups, such as athletes. Known as a demanding patient population, athletes have unique needs.

View Article and Find Full Text PDF

Radiomic signatures of brain metastases on MRI: utility in predicting pathological subtypes of lung cancer.

Transl Cancer Res

December 2024

Department of Radiology, Shanghai Chest Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.

Background: The pathological sub-classification of lung cancer is crucial in diagnosis, treatment and prognosis for patients. Quick and timely identification of pathological subtypes from imaging examinations rather than histological tests could help guiding therapeutic strategies. The aim of the study is to construct a non-invasive radiomics-based model for predicting the subtypes of lung cancer on brain metastases (BMs) from multiple magnetic resonance imaging (MRI) sequences.

View Article and Find Full Text PDF

Background: Bladder urothelial carcinoma (BLCA) is globally recognized as a prevalent malignancy. Its treatment remains challenging due to the extensive morbidity, high mortality rates, and compromised quality of life from postoperative complications and the lack of specific molecular targets. Our aim was to establish a prognostic model to evaluate the prognostic significance, assess immunotherapy responses, and determine drug susceptibility in patients with BLCA.

View Article and Find Full Text PDF

Background: Within the realm of primary brain tumors, specifically glioblastoma (GBM), presents a notable obstacle due to their unfavorable prognosis and differing median survival rates contingent upon tumor grade and subtype. Despite a plethora of research connecting cardiotrophin-1 (CTF1) modifications to a range of illnesses, its correlation with glioma remains uncertain. This study investigated the clinical value of CTF1 in glioma and its potential as a biomarker of the disease.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!